What 4 Analyst Ratings Have To Say About Arrowhead Pharma
Portfolio Pulse from Benzinga Insights
Arrowhead Pharma (NASDAQ:ARWR) received 4 analyst ratings in the last quarter with 1 bullish, 1 somewhat bullish, and 2 indifferent. The average price target is $37.25, representing an implied upside from the current price of $23.21. This target is a 6.88% decrease from the previous target of $40.00. Analyst ratings are opinions based on financial analysis and are updated quarterly.
December 04, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Arrowhead Pharma received mixed analyst ratings with an average price target of $37.25, suggesting a potential upside from the current price of $23.21.
The average price target suggests a bullish sentiment among analysts, despite the recent decrease in target price. The ratings indicate that analysts believe the stock has potential for growth, which could positively influence the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100